CGCeleste Patricia Gazcón-Rivas

Celeste Patricia Gazcón-Rivas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Celeste Patricia Gazcón-Rivas has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Ana María Puebla-Pérez

    Laboratorio de Inmunofarmacología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara (UdeG), Guadalajara 44430, Jalisco, Mexico

    1 shared publication
  • Asbiel Felipe Garibaldi-Ríos

    División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • Belinda Claudia Gómez-Meda

    Instituto de Genética Humana “Dr. Enrique Corona Rivera”, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • Blanca Miriam Torres-Mendoza

    Laboratorio de Inmunodeficiencias Humanas y Retrovirus, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • Elvia Harumi Scott-López

    Laboratorio de Salud en el Trabajo, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • Guillermo Moisés Zúñiga-González

    División de Medicina Molecular, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico

    1 shared publication

Latest Publications

  • Open Access

    Lead Poisoning in the Americas: Sources, Regulations, Health Impacts, and Molecular Mechanisms

    by Blanca Miriam Torres-Mendoza, Asbiel Felipe Garibaldi-Ríos, Lourdes Del Carmen Rizo De La Torre, Ana María Puebla-Pérez, Luis E. Figuera, Guillermo Moisés Zúñiga-González, Belinda Claudia Gómez-Meda, Itzae Adonai Gutiérrez-Hurtado, Elvia Harumi Scott-López, Verónica Vázquez-González, et al.

    Lead poisoning is a significant public health issue, contributing to 0.6% of the global disease burden and disproportionately affecting developing countries. Vulnerable populations, such as children, pregnant women, and low-income communities, remain at high risk, often exposed to lead levels exceeding safe thresholds. While the problem is global, this review focuses specifically on the Americas, regions with diverse regulatory landscapes and persistent environmental lead exposure. Regulatory frameworks vary widely, and the lack of global consensus on acceptable blood lead levels leaves important gaps in protection. This review compiles and updates knowledge on emerging sources of lead exposure in the region, evaluates advancements in regulatory approaches, and analyzes the molecular impacts of lead on human health. Using the Comparative Toxicogenomics Database (CTD), lead was found to interact with 3448 genes, including those linked to inflammation and oxidative stress, and is associated with 4401 diseases and 799 disrupted pathways. These findings emphasize the need for regionally tailored interventions, strengthened policies, and further research on its health impacts.